New York, NY (PRWEB) July 03, 2012
The Rottenstein Law Group, which represents clients who claim they suffered harm as a result of having taken the type 2 diabetes drug Actos, is publicizing yet another study suggesting that Actos might cause bladder cancer.
At the University of Alberta School of Public Health, analysis of previously completed studies showed that Actos (generic name: pioglitazone) raised the risk of bladder cancer by 22%. These findings were published in the July 3, 2012, edition of the Canadian Medical Association Journal (CMAJ), according to an article published on Newsday.com that same day.
The findings published in the CMAJ were based on researchers' analysis of data from previous studies involving 2.6 million people with type 2 diabetes who were prescribed drugs from the class known as thiazolidinediones, of which Actos is a member, according to Newsday.com. From that group, 3,643 people were newly diagnosed with bladder cancer, Newsday.com reported.
The study's authors believe the increased risk for bladder cancer is associated with the ability of drugs like Actos to affect the body's production of insulin, which cancer cells can use to grow and multiply, according to Newsday.com. The study's senior author, Jeffrey A. Johnson, the Canada Research Chair in Diabetes Health Outcomes at the University of Alberta School of Public Health, “suspects the link between Actos and bladder cancer would have to be the result of a direct effect of the medication,” the Newsday.com article states.
The Rottenstein Law Group advises anyone who has suffered adverse side effects from taking Actos or any other medication to speak with a qualified personal injury lawyer as soon as possible. The Rottenstein Law Group maintains an Actos Lawsuit Information Page, at http://www.rotlaw.com/takeda-actos/, that has social media features that allow for easy sharing on sites like Facebook and Twitter, enabling visitors to spread the word about the dangers of Actos.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site at http://www.rotlaw.com, or call (888) 9-ROT-LAW.
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W 44, Suite 511
New York, NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)